Oramed Reports Positive Top-Line Results from Phase 2 NASH Trial with its ORMD-0801, Oral Insulin Candidate September 13, 2022 Press Releases
Oramed to Present at H.C. Wainwright 24th Annual Global Investment Conference September 6, 2022 Press Releases
Oramed to Present at the Upcoming Canaccord Genuity Annual Growth Conference July 11, 2022 Press Releases
